"10.1371_journal.pone.0007611","plos one","2009-10-27T00:00:00Z","Bertrand Lell; Selidji Agnandji; Isabelle von Glasenapp; Sonja Haertle; Sunny Oyakhiromen; Saadou Issifou; Johan Vekemans; Amanda Leach; Marc Lievens; Marie-Claude Dubois; Marie-Ange Demoitie; Terrell Carter; Tonya Villafana; W Ripley Ballou; Joe Cohen; Peter G Kremsner","Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon; GlaxoSmithKline, Biologicals, Rixensart, Belgium; PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany","Conceived and designed the experiments: BL JV AL ML MCD MAD TC TV WRB JC PGK. Performed the experiments: BL STA IvG SH SO SI TC TV WRB PGK. Analyzed the data: BL JV AL ML WRB JC PGK. Contributed reagents/materials/analysis tools: STA IvG SH SO SI MCD MAD. Wrote the paper: BL STA IvG SH SO SI JV AL ML MCD MAD TC TV WRB JC PGK.","M.A.D., M-C.D., A.L., M.L., J.V., J.C. are employees of GSK Biologicals. A.L., J.C. and M.C.D. own shares in GSK. W.R.B. was an employee of GSK Biologicals during study design and implementation, but became an employee of the Gates Foundation by the time results were available. J.C. and W.R.B. are listed as inventors of patented malaria vaccines, however, neither individual holds a patent for a malaria vaccine. There are no conflicts of interest for other authors.","2009","10","Bertrand Lell","BL",16,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
